AZO Yeast Plus Candida Albicans, Wood Creosote, Sodium Chloride, and Sulfur 30 [hp_X]/1; 30 [hp_X]/1; 12 [hp_X]/1; 12 [hp_X]/1 Tablet, 20-count — NDC 49973-667-20 (Billing 49973-0667-20)
This is a package of 20 tablets of AZO Yeast Plus Candida Albicans, Wood Creosote, Sodium Chloride, and Sulfur 30 [hp_X]/1; 30 [hp_X]/1; 12 [hp_X]/1; 12 [hp_X]/1 Tablet from i-Health, Inc., marketed since Jan 2014 and currently FDA-listed. It is the main listing for this product, which comes in 3 package sizes.
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
Clinical
AZO Yeast Plus is an oral tablet marketed as a homeopathic product. It contains candida albicans, wood creosote, sulfur, and sodium chloride in homeopathic potencies. In homeopathic practice, these ingredients are traditionally used to address yeast-related concerns and skin conditions, though homeopathic products are not evaluated by the FDA for effectiveness and are marketed based on homeopathic tradition rather than clinical evidence.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 2, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 49973-0667-20 You're viewing this Main listing | 20 BLISTER PACK in 1 BOX / 1 TABLET in 1 BLISTER PACK | 2018-04-25 | — | Active |
| 49973-0667-60 49973-667-60 | 60 BLISTER PACK in 1 BOX / 1 TABLET in 1 BLISTER PACK | 2014-04-01 | — | Active |
| 49973-0667-62 49973-667-62 | 120 BLISTER PACK in 1 BOX / 4 TABLET in 1 BLISTER PACK | 2025-05-14 | — | Active |
Pack size FAQ
What quantity is in this package?
How does this package differ from NDC 49973-0667-60?
What NDC number is used to bill for this package of AZO Yeast Plus Candida Albicans, Wood Creosote, Sodium Chloride, and Sulfur 30 [hp_X]/1; 30 [hp_X]/1; 12 [hp_X]/1; 12 [hp_X]/1 Tablet?
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| AZO Yeast Plus 30 [hp_X]/1; 30 [hp_X]/1; 12 [hp_X]/1; 12 [hp_X]this 49973-0667-20 | i-Health, | 20 tablets | — | — | FDA listed | — |
| Equate Yeast Relief 30 [hp_X]/1; 30 [hp_X]/1; 12 [hp_X]/1; 12 [hp_X] 79903-0094-14 | WAL-MART | 60 tablets | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Sep 3, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Sep 3, 2026
What it looks like
Where does this data come from?
- FDA label on DailyMed · label index refreshed Oct 1, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Oct 1, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Use: See your doctor if this is the first time you have vaginal itching and discomfort to find out if you have a vaginal yeast infection. Relieves the symptoms of itching and burning associated with vaginal yeast infections. Relieves occasional vaginal odor and discharge.
⏱️ Dosage and Administration ▾
Directions: Adults: take one tablet orally three times a day as long as symptoms persist. Children: consult a physician prior to use. For occasional support take one tablet per day.
⚠️ Warnings ▾
Warnings: For oral use only. This product will not cure a yeast infection. Do not use if you have never had a vaginal yeast infection diagnosed by a doctor.
Ask a doctor before use if you have vaginal itching and discomfort for the first time. have abdominal pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge. You may have a serious condition. get vaginal yeast infections often (such as once a month or three in six months). may have been exposed to human immunodeficiency virus (HIV) that causes AIDS. Stop use and contact your physician if your symptoms do not improve within 3 days or if symptoms last more than 7 days. you get a rash, hives, abdominal pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge.
If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
🧪 Active Ingredient ▾
Active Ingredients (in each tablet): Candida albicans 30X Kreosotum 30X Natrium muriaticum 12X Sulphur 12X
🧪 Inactive Ingredients ▾
Inactive Ingredients: Dicalcium phosphate, fractionated cocunut and palm kernel oil, hypromellose, magnesium stearate, and microcrystalline cellulose.
🎯 Purpose ▾
Purpose Relief from vaginal itching, burning and discharge Relief from vaginal itching, burning, odor and discharge Relief from vaginal itching, burning, odor and discharge Relief from vaginal itching, burning, odor and discharge
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
About homeopathic listings
AZO Yeast Plus Candida Albicans, Wood Creosote, Sodium Chloride, and Sulfur 30 [hp_X]/1; 30 [hp_X]/1; 12 [hp_X]/1; 12 [hp_X]/1 TABLET is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |